phone icon (917) 310-3371 Explore YEZTUGO PrEP Menu
Nao Medical Logo

YEZTUGO twice-yearly PrEP in NYC and Long Island

Nao Medical is building a YEZTUGO launch-readiness lane around coverage support, six-month PrEP planning, and the locations that could actually administer it once operations are live.

YEZTUGO is the twice-yearly lenacapavir PrEP option for people who want the longest dosing interval currently available, but the access path is still operationally heavier than a same-day pill pickup. Launch-ready care means the site, the medication-sourcing path, the HIV testing workflow, and the follow-up cadence all have to be lined up.

YEZTUGO is given as two subcutaneous injections every 6 months after starter dosing. On day 1, the patient receives two oral tablets and two injections in a medical setting. On day 2, two more oral tablets are taken at home. HIV testing is required before starting and before each injection visit.

Coverage support for YEZTUGO is still evolving. Official patient resources point patients to Gilead Advancing Access for benefits investigation, prior-authorization support, co-pay help for eligible commercially insured patients, and medication-assistance pathways for some uninsured patients. NYC guidance also notes that insurance policies are still changing and coverage can vary by payer.

YEZTUGO needs a real operating plan A strong YEZTUGO page does not just repeat that it is twice yearly. It explains what has to be true before a clinic can genuinely deliver it well.

What the YEZTUGO lane actually covers

Nao Medical is building a YEZTUGO launch-readiness lane for twice-yearly PrEP access, coverage support, and site planning across NYC and Long Island. These pages are written to explain the operational path clearly without pretending every location is already live for YEZTUGO administration today.

What this lane is for

This lane is for people interested in YEZTUGO and the teams planning how it could go live safely and credibly across the Nao network.

What patients should expect

YEZTUGO is the longest-acting PrEP option available, but it still depends on HIV testing, a clinical administration setting, medication access, and reliable follow-up.

What launch readiness means

Launch readiness means the site can really handle testing, procurement, storage, scheduling, billing, and the six-month follow-up cycle before it is marketed as active.

Why planned-site pages are still useful

A truthful planned-site footprint helps patients and staff understand where the rollout is most likely to make sense once operations turn on.

Twice-yearly access, launch readiness, and coverage support

YEZTUGO is given as two subcutaneous injections every 6 months after starter dosing. On day 1, the patient receives two oral tablets and two injections in a medical setting. On day 2, two more oral tablets are taken at home. HIV testing is required before starting and before each injection visit.

Launch readiness for YEZTUGO means more than writing a page or placing the drug on a list. Sites need procurement and specialty-pharmacy routing, staff training on subcutaneous administration, storage and handling workflow, scheduling logic for six-month follow-up, HIV testing workflow, billing setup, and a clear plan for delayed injections.

Gilead Advancing Access can help with benefits investigations, prior authorization, co-pay program enrollment for eligible commercially insured patients, and medication-assistance pathways. The program can be reached at 1-800-226-2056.

Planned YEZTUGO administration sites across New York

These are the locations that fit the rollout conversation once YEZTUGO operations are live. Each local page explains readiness and expectations rather than implying universal immediate availability.

174th Street YEZTUGO planned administration site

Bronx

174th Street

932 E 174th St, Bronx, NY 10460

A Bronx site planned for YEZTUGO administration once operations go live, serving patients in West Farms, Crotona Park East, and nearby Bronx neighborhoods with twice-yearly PrEP planning and six-month follow-up.

View YEZTUGO site page Get directions
Astoria YEZTUGO planned administration site

Queens

Astoria

37-15 23rd Ave, Astoria, NY 11105

A Queens site planned for YEZTUGO administration once operations go live, serving patients in Astoria, Ditmars, East Elmhurst, and nearby Queens neighborhoods with twice-yearly PrEP planning and six-month follow-up.

View YEZTUGO site page Get directions
Bartow Mall YEZTUGO planned administration site

Bronx

Bartow Mall

2063A Bartow Ave, Bronx, NY 10475

A Bronx site planned for YEZTUGO administration once operations go live, serving patients in Co-op City, Pelham Bay, Baychester, and nearby Bronx neighborhoods with twice-yearly PrEP planning and six-month follow-up.

View YEZTUGO site page Get directions
Crown Heights YEZTUGO planned administration site

Brooklyn

Crown Heights

341 Eastern Pkwy, Brooklyn, NY 11216

A Brooklyn site planned for YEZTUGO administration once operations go live, serving patients in Crown Heights, Prospect Heights, and nearby Brooklyn neighborhoods with twice-yearly PrEP planning and six-month follow-up.

View YEZTUGO site page Get directions
Hicksville YEZTUGO planned administration site

Long Island

Hicksville

232 W Old Country Rd, Hicksville, NY 11801

A Long Island site planned for YEZTUGO administration once operations go live, serving patients in Hicksville, Plainview, Bethpage, and nearby Nassau County communities with twice-yearly PrEP planning and six-month follow-up.

View YEZTUGO site page Get directions
Jackson Heights YEZTUGO planned administration site

Queens

Jackson Heights

80-10 Northern Blvd, Jackson Heights, NY 11372

A Queens site planned for YEZTUGO administration once operations go live, serving patients in Jackson Heights, Elmhurst, Corona, and nearby Queens neighborhoods with twice-yearly PrEP planning and six-month follow-up.

View YEZTUGO site page Get directions
Jamaica YEZTUGO planned administration site

Queens

Jamaica

90-18 Sutphin Blvd, Jamaica, NY 11435

A Queens site planned for YEZTUGO administration once operations go live, serving patients in Jamaica, Briarwood, Richmond Hill, and nearby Queens neighborhoods with twice-yearly PrEP planning and six-month follow-up.

View YEZTUGO site page Get directions
Long Island City YEZTUGO planned administration site

Queens

Long Island City

30-07 36th Ave, Astoria, NY 11106

A Queens site planned for YEZTUGO administration once operations go live, serving patients in Long Island City, Astoria, Sunnyside, and nearby Queens neighborhoods with twice-yearly PrEP planning and six-month follow-up.

View YEZTUGO site page Get directions
Mineola YEZTUGO planned administration site

Long Island

Mineola

135 Mineola Blvd, Mineola, NY 11501

A Long Island site planned for YEZTUGO administration once operations go live, serving patients in Mineola, Garden City, Westbury, and nearby Nassau County communities with twice-yearly PrEP planning and six-month follow-up.

View YEZTUGO site page Get directions
StuyTown YEZTUGO planned administration site

Manhattan

StuyTown

259 1st Ave, New York, NY 10003

A Manhattan site planned for YEZTUGO administration once operations go live, serving patients in StuyTown, East Village, Gramercy, and nearby Manhattan neighborhoods with twice-yearly PrEP planning and six-month follow-up.

View YEZTUGO site page Get directions
Williamsburg YEZTUGO planned administration site

Brooklyn

Williamsburg

308 Graham Ave, Brooklyn, NY 11211

A Brooklyn site planned for YEZTUGO administration once operations go live, serving patients in Williamsburg, Greenpoint, Bushwick, and nearby Brooklyn neighborhoods with twice-yearly PrEP planning and six-month follow-up.

View YEZTUGO site page Get directions

Use the right page for the right next step

Twice-yearly access

Use the twice-yearly access page for starter dosing, six-month scheduling, testing, and shipment timing.

Launch readiness

Use the launch-readiness page when the real question is whether a clinic is operationally ready for YEZTUGO yet.

Coverage support

Use the coverage page when the blocker is prior authorization, payer routing, or Advancing Access support.

Administration sites

Use the sites page when the question is which NYC and Long Island clinics are the real rollout candidates once operations are live.

Current long-acting PrEP option

Use the APRETUDE lane if the patient wants the currently established long-acting PrEP path on this site while YEZTUGO readiness continues.

HIV and STI testing

Use the HIV and STD testing hubs when the immediate need is testing, follow-up, or broader sexual-health support.

Questions about YEZTUGO

YEZTUGO is lenacapavir for HIV PrEP, approved as a twice-yearly injectable option for adults and adolescents weighing at least 35 kg who are HIV negative and would benefit from PrEP.
YEZTUGO is given as two subcutaneous injections every 6 months after starter dosing. On day 1, the patient receives two oral tablets and two injections in a medical setting. On day 2, two more oral tablets are taken at home. HIV testing is required before starting and before each injection visit.
No. This cluster is written as launch-readiness content. The pages identify planned administration sites and explain what has to be operational before YEZTUGO should be marketed as actively available at a specific clinic.
Launch readiness for YEZTUGO means more than writing a page or placing the drug on a list. Sites need procurement and specialty-pharmacy routing, staff training on subcutaneous administration, storage and handling workflow, scheduling logic for six-month follow-up, HIV testing workflow, billing setup, and a clear plan for delayed injections.
Coverage support for YEZTUGO is still evolving. Official patient resources point patients to Gilead Advancing Access for benefits investigation, prior-authorization support, co-pay help for eligible commercially insured patients, and medication-assistance pathways for some uninsured patients. NYC guidance also notes that insurance policies are still changing and coverage can vary by payer. Gilead Advancing Access can help with benefits investigations, prior authorization, co-pay program enrollment for eligible commercially insured patients, and medication-assistance pathways. The program can be reached at 1-800-226-2056.
If the next six-month injection is expected to be delayed by more than two weeks, the plan should be reviewed right away. Official HCP materials describe weekly oral lenacapavir as an interim option in some delayed-injection situations, and restarting initiation if enough time has passed without injections or oral backup.

200,000+ 5-star reviews

What patients say about Nao Medical

Verified Patient
(4.9)

This YEZTUGO hub was more honest than most launch pages.

Verified Patient
(4.9)

Helpful that it explained what operations-live actually means.

Verified Patient
(4.9)

The coverage and readiness sections felt practical instead of promotional.

Verified Patient
(4.9)

Good page for understanding how twice-yearly PrEP would actually roll out.

Verified Patient
(4.9)

The planned-site framing felt much more credible than pretending every location was already ready.

Verified Patient
(4.9)

Useful bridge page between current long-acting PrEP and the newer YEZTUGO option.

Nao medical

Start with readiness, not assumptions

Use the readiness and planned-site pages first so the YEZTUGO rollout is understood clearly before anyone assumes immediate same-day availability.

Review launch readiness